LH — LABCORP HOLDINGS INC.

—
NYSE · Health Care · Health Care Providers & Services · CIK 920148 ·
Last close
$368.24
Market Cap
$29.90B
52W High
$375.10
52W Low
$243.20
ADV30
714,216
Next earnings
2026-10-28

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 3,731,100,000 1,112,000,000 456,700,000 298,700,000 18,532,300,000 141,800,000 9,909,100,000
Mar 2026 3,537,600,000 1,013,800,000 387,200,000 277,800,000 19,087,100,000 981,100,000 10,341,600,000
Dec 2025 3,515,800,000 993,200,000 382,000,000 164,700,000 18,392,700,000 532,300,000 9,756,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,638,400,000
Investing CF
$-1,452,200,000
Financing CF
$-689,300,000
CapEx
$-483,200,000
Dividends Paid
$-239,100,000
Buybacks
$-701,800,000
EPS Diluted TTM
$12.19
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$8,701,400,000
Inventory
$562,200,000
Receivables
$2,504,800,000
ST Investments
—
EBIT TTM
$1,460,900,000
Pretax Income TTM
$1,233,700,000
Interest Exp TTM
$227,200,000
Analysts
16

Yahoo Snapshot (yfinance, live)

Total Revenue
$14,594,499,584
EBITDA
$2,347,300,096
Free Cash Flow
$1,058,700,032
Enterprise Value
$35,875,069,952
Total Cash
$261,800,000
Total Debt
$6,775,900,160
Shares Out
81,200,000
Trailing EPS
$12.20
Book Value
$108.96
ROE
11.4%
ROA
5.5%
Div Yield
0.80%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 13,951,700,000 1,516,200,000 876,500,000 18,392,700,000 9,756,000,000 8,619,800,000 1,640,500,000
Dec 2024 13,008,900,000 1,138,000,000 746,000,000 18,379,000,000 10,312,500,000 8,052,200,000 1,585,800,000
Dec 2023 12,161,600,000 1,123,700,000 418,000,000 16,725,100,000 8,834,600,000 7,875,000,000 1,327,700,000
Dec 2022 11,863,900,000 1,752,200,000 1,279,100,000 20,155,100,000 10,039,600,000 10,096,600,000 1,955,900,000

TTM Snapshot

Revenues TTM
$14,348,000,000
NetIncome TTM
$1,002,300,000
OpCashFlow TTM
—
Assets (Latest)
$18,532,300,000
Forward EPS
$19.56

Max Pain — expiry 2027-01-15

max pain strike: $290.00 · spot: $370.78 · call oi: 2,594 · put oi: 372
Expected Move to 2027-01-15: ±$28.40 (7.66%) — implied range $342.38 – $399.18 · ATM straddle on $370.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
DGX QUEST DIAGNOSTICS INC $28.29B $256.35 —
THC TENET HEALTHCARE CORP $22.45B $282.07 —
NTRA Natera, Inc. $41.68B $287.47 —
GH Guardant Health, Inc. $19.38B $143.28 —
BTSG BrightSpring Health Services, Inc. $13.90B $69.83 —

News headlines (Yahoo Finance, 1h cache)

OTraces Selects Labcorp to Perform Biomarker Testing for Florida Department of Health–Funded Prostate Cancer Study
2026-11-18 13:30 · Yahoo
Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo Fleury
2026-11-17 21:30 · Yahoo
Clinical Trials Support Services - Global Strategic Business Report 2026: Capitalize on $15 Billion in New Revenue by 2032 as IQVIA, ICON, Labcorp, Parexel and Veeva Disrupt Trials with AI
2026-11-16 15:46 · Yahoo
Rare Disease Clinical Trials - Global Strategic Business Report 2026: Capitalize on the $19.5 Billion Market as IQVIA, ICON, Parexel, and Labcorp Disrupt Trial Economics by 2032
2026-11-16 15:44 · Yahoo
Labcorp (LH) Stock Sees Fair Value Lift After Q3 Analyst Target Increases
2026-11-14 14:11 · Yahoo
Labcorp (LH) Stock Looks About Right After Its Recent Run
2026-11-14 11:10 · Yahoo
Is Labcorp Holdings (LH) Still Cheap Following Its UBS Healthcare Conference Appearance?
2026-11-14 09:10 · Yahoo
Should Labcorp Stock Holders Look At Quest Diagnostics Instead?
2026-11-13 17:25 · Yahoo
Labcorp’s Lab Growth Surges as $125 Million Reimbursement Risk Looms
2026-11-13 16:14 · Yahoo
Labcorp: 3 Key Takeaways for Long-Term Investors
2026-11-13 00:41 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.